BACKGROUND: Chronic intake of ethanol (EtOH) has been linked to serious health consequences such as cardiac and liver problems, cognitive impairments, and brain damage. Alcohol's detrimental effects depend upon the dose, duration, and pattern of exposure with binge drinking as one of the most common, but most damaging, patterns of intake. Little is known about the threshold of the damaging effects of alcohol. Therefore, these experiments sought to determine a threshold for brain damage using various markers of neurodegeneration. METHODS: Adult male Sprague-Dawley rats were administered nutritionally complete liquid diet containing either EtOH (25% w/v) or isocaloric dextrose every 8 hours for either 1 (mean dose, 13.4 ± 0.3 g/kg/d; mean blood EtOH concentration (BEC), 336.2 ± 18.8 mg/dl) or 2 days (mean dose, 10.9 ± 0.3 g/kg/d; mean BEC, 369.8 ± 18.1 mg/dl). On the basis of a known time course of various neurodegeneration-associated events, rats were perfused transcardially immediately following, 2 days after, or 7 days post EtOH exposure. To label actively dividing cells, some animals were injected with BromodeoxyUridine (BrdU) 2 hours prior to perfusion. Tissue was then analyzed for the presence of BrdU (cell proliferation), FluoroJade B (degenerative neurons), and vimentin (reactive astrogliosis) immunoreactivity. RESULTS: One or 2 days of EtOH exposure failed to alter cell proliferation at any of the time points analyzed. However, significant 2- to 9-fold increases in neuronal degeneration in limbic cortex and clear evidence of reactive gliosis as indicated by a 2- to 8-fold upregulation in vimentin immunoreactivity in the hippocampus were observed following as little as 1 day of binge EtOH exposure. CONCLUSIONS: These results indicate that as little as 1 day (24 hours) of high BEC, binge-like EtOH exposure is enough to elicit signs of alcohol-induced brain damage in adult rats. Further, reactive gliosis may be a more sensitive marker of alcohol-induced damage in the hippocampus.
BACKGROUND: Chronic intake of ethanol (EtOH) has been linked to serious health consequences such as cardiac and liver problems, cognitive impairments, and brain damage. Alcohol's detrimental effects depend upon the dose, duration, and pattern of exposure with binge drinking as one of the most common, but most damaging, patterns of intake. Little is known about the threshold of the damaging effects of alcohol. Therefore, these experiments sought to determine a threshold for brain damage using various markers of neurodegeneration. METHODS: Adult male Sprague-Dawley rats were administered nutritionally complete liquid diet containing either EtOH (25% w/v) or isocaloric dextrose every 8 hours for either 1 (mean dose, 13.4 ± 0.3 g/kg/d; mean blood EtOH concentration (BEC), 336.2 ± 18.8 mg/dl) or 2 days (mean dose, 10.9 ± 0.3 g/kg/d; mean BEC, 369.8 ± 18.1 mg/dl). On the basis of a known time course of various neurodegeneration-associated events, rats were perfused transcardially immediately following, 2 days after, or 7 days post EtOH exposure. To label actively dividing cells, some animals were injected with BromodeoxyUridine (BrdU) 2 hours prior to perfusion. Tissue was then analyzed for the presence of BrdU (cell proliferation), FluoroJade B (degenerative neurons), and vimentin (reactive astrogliosis) immunoreactivity. RESULTS: One or 2 days of EtOH exposure failed to alter cell proliferation at any of the time points analyzed. However, significant 2- to 9-fold increases in neuronal degeneration in limbic cortex and clear evidence of reactive gliosis as indicated by a 2- to 8-fold upregulation in vimentin immunoreactivity in the hippocampus were observed following as little as 1 day of binge EtOH exposure. CONCLUSIONS: These results indicate that as little as 1 day (24 hours) of high BEC, binge-like EtOH exposure is enough to elicit signs of alcohol-induced brain damage in adult rats. Further, reactive gliosis may be a more sensitive marker of alcohol-induced damage in the hippocampus.
Authors: A Pfefferbaum; K O Lim; R B Zipursky; D H Mathalon; M J Rosenbloom; B Lane; C N Ha; E V Sullivan Journal: Alcohol Clin Exp Res Date: 1992-12 Impact factor: 3.455
Authors: Fulton T Crews; Michael A Collins; Cynthia Dlugos; John Littleton; Lincoln Wilkins; Edward J Neafsey; Roberta Pentney; Lawrence D Snell; Boris Tabakoff; Jian Zou; Antonio Noronha Journal: Alcohol Clin Exp Res Date: 2004-02 Impact factor: 3.455
Authors: Isabella R Grifasi; Scot E McIntosh; Rhiannon D Thomas; Donald T Lysle; Todd E Thiele; S Alex Marshall Journal: Neuroimmunomodulation Date: 2019-01-09 Impact factor: 2.492
Authors: Chelsea R Geil; Dayna M Hayes; Justin A McClain; Daniel J Liput; S Alex Marshall; Kevin Y Chen; Kimberly Nixon Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2014-05-17 Impact factor: 5.067
Authors: Jun Xu; Hsiao-Yen Ma; Xiao Liu; Sara Rosenthal; Jacopo Baglieri; Ryan McCubbin; Mengxi Sun; Yukinori Koyama; Cedric G Geoffroy; Kaoru Saijo; Linshan Shang; Takahiro Nishio; Igor Maricic; Max Kreifeldt; Praveen Kusumanchi; Amanda Roberts; Binhai Zheng; Vipin Kumar; Karsten Zengler; Donald P Pizzo; Mojgan Hosseini; Candice Contet; Christopher K Glass; Suthat Liangpunsakul; Hidekazu Tsukamoto; Bin Gao; Michael Karin; David A Brenner; George F Koob; Tatiana Kisseleva Journal: JCI Insight Date: 2020-02-13
Authors: Jeremy W Duncan; Xiao Zhang; Niping Wang; Shakevia Johnson; Sharonda Harris; Chinelo Udemgba; Xiao-Ming Ou; Moussa B Youdim; Craig A Stockmeier; Jun Ming Wang Journal: Neuropharmacology Date: 2016-01-22 Impact factor: 5.250
Authors: Cynthia J M Kane; Kevin D Phelan; James C Douglas; Gail Wagoner; Jennifer Walker Johnson; Jihong Xu; Paul D Drew Journal: J Neuroinflammation Date: 2013-05-23 Impact factor: 8.322